Pulmonary Hypertension in preterm children born at gestational age <30 weeks: Prevalence, risk factors and outcome.

Pulmonary Hypertension in preterm children born at gestational age <30 weeks: Prevalence, risk factors and outcome. - Neolifes-Heart

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44035

Enrollment

165

Registered

2016-04-29

Start date

2016-06-13

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonale hypertensie Pulmonary Hypertension

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: All premature infants, admitted at the neonatology UMCG, born

Exclusion criteria

Exclusion criteria: no informed consent.

Design outcomes

Primary

Measure	Time frame
The presence of PH (incidence and prevalence).	—

Secondary

Measure	Time frame
Morbidity, Mortality: Quality of life questionnaire and survival. Maternal factors: mode of conception, delivery, preterm premature rupture of membranes, maternal disease history, illnesses during gestation, tabacco and medication use. Perinatal variables: slow growth patterns in utero, prenatal echo findings, PROM, chorionamniotis, oligoamnion, birth events, placental histology. Neonatal variables: development of BPD, low birth weight, gestational age, skull circumference, pulmonary and artficial ventilation variables, oxygen need, presence of PDA, medication, infections, renal function, complications (NEC), slow growth at GA 36wks and at discharge. other: demographics, slow growth, admissions, medication, feeding, neurological development, respiratory symptoms, lung clearing index.	—

Measure

Time frame

Morbidity, Mortality: Quality of life questionnaire and survival. Maternal factors: mode of conception, delivery, preterm premature rupture of membranes, maternal disease history, illnesses during gestation, tabacco and medication use. Perinatal variables: slow growth patterns in utero, prenatal echo findings, PROM, chorionamniotis, oligoamnion, birth events, placental histology. Neonatal variables: development of BPD, low birth weight, gestational age, skull circumference, pulmonary and artficial ventilation variables, oxygen need, presence of PDA, medication, infections, renal function, complications (NEC), slow growth at GA 36wks and at discharge. other: demographics, slow growth, admissions, medication, feeding, neurological development, respiratory symptoms, lung clearing index.

—

Countries

Netherlands

Outcome results